Akebia Therapeutics, Inc. (AKBA)
0.8741
-0.04
(-4.76%)
USD |
NASDAQ |
Sep 17, 13:52
Akebia Therapeutics Total Return Level : 0.9178 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 0.9178 |
| September 15, 2026 | 0.903 |
| September 14, 2026 | 0.9629 |
| September 11, 2026 | 0.9517 |
| September 10, 2026 | 0.9465 |
| September 09, 2026 | 0.9539 |
| September 08, 2026 | 1.03 |
| September 04, 2026 | 0.9747 |
| September 03, 2026 | 0.9833 |
| September 02, 2026 | 0.9803 |
| September 01, 2026 | 0.9447 |
| August 31, 2026 | 0.9188 |
| August 28, 2026 | 0.8786 |
| August 27, 2026 | 0.9398 |
| August 26, 2026 | 0.9065 |
| August 25, 2026 | 0.9584 |
| August 24, 2026 | 0.9006 |
| August 21, 2026 | 0.9066 |
| August 20, 2026 | 0.9194 |
| August 19, 2026 | 0.8854 |
| August 18, 2026 | 0.8518 |
| August 17, 2026 | 0.86 |
| August 14, 2026 | 0.8728 |
| August 13, 2026 | 0.8696 |
| August 12, 2026 | 0.8932 |
| Date | Value |
|---|---|
| August 11, 2026 | 0.8665 |
| August 10, 2026 | 0.844 |
| August 07, 2026 | 0.9099 |
| August 06, 2026 | 0.9544 |
| August 05, 2026 | 1.29 |
| August 04, 2026 | 1.32 |
| August 03, 2026 | 1.31 |
| July 31, 2026 | 1.32 |
| July 30, 2026 | 1.35 |
| July 29, 2026 | 1.26 |
| July 28, 2026 | 1.27 |
| July 27, 2026 | 1.28 |
| July 24, 2026 | 1.22 |
| July 23, 2026 | 1.22 |
| July 22, 2026 | 1.26 |
| July 21, 2026 | 1.30 |
| July 20, 2026 | 1.28 |
| July 17, 2026 | 1.34 |
| July 16, 2026 | 1.40 |
| July 15, 2026 | 1.38 |
| July 14, 2026 | 1.40 |
| July 13, 2026 | 1.38 |
| July 10, 2026 | 1.40 |
| July 09, 2026 | 1.43 |
| July 08, 2026 | 1.42 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Emergent BioSolutions, Inc. | 6.75 |
| Exelixis, Inc. | 56.78 |
| ADMA Biologics, Inc. | 8.90 |
| Arcutis Biotherapeutics, Inc. | 26.14 |
| Relay Therapeutics, Inc. | 18.84 |